Jaskanwal D Sara1, R Jay Widmer1, Yasushi Matsuzawa1, Ryan J Lennon2, Lilach O Lerman3, Amir Lerman4. 1. Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, Minnesota. 2. Division of Biomedical Statistics and Informatics, Mayo College of Medicine, Rochester, Minnesota. 3. Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota. 4. Division of Cardiovascular Diseases, Mayo College of Medicine, Rochester, Minnesota. Electronic address: lerman.amir@mayo.edu.
Abstract
OBJECTIVES: This study assessed the prevalence of coronary microvascular abnormalities in patients presenting with chest pain and nonobstructive coronary artery disease (CAD). BACKGROUND: Coronary microvascular abnormalities mediate ischemia and can lead to an increased risk of cardiovascular events. METHODS: Using an intracoronary Doppler guidewire, endothelial-dependent microvascular function was examined by evaluating changes in coronary blood flow in response to acetylcholine, whereas endothelial-independent microvascular function was examined by evaluating changes in coronary flow velocity reserve in response to intracoronary adenosine. Patients were divided into 4 groups depending on whether they had a normal (+) or abnormal (-) coronary blood flow (CBF) in response to acetylcholine (Ach) and a normal (+) or abnormal (-) coronary flow velocity reserve (CFR) in response to adenosine (Adn): CBFAch+, CFRAdn+ (n = 520); CBFAch-, CFRAdn+ (n = 478); CBFAch+, CFRAdn- (n = 173); and CBFAch-, CFRAdn- (n = 268). RESULTS: Two-thirds of all patients had some sort of microvascular dysfunction. Women were more prevalent in each group (56% to 82%). Diabetes was uncommon in all groups (7% to 12%), whereas hypertension and hyperlipidemia were relatively more prevalent in each group, although rates for most conventional cardiovascular risk factors did not differ significantly between groups. There were no significant differences in the findings of noninvasive functional testing between groups. In a multivariable analysis, age was the only variable that independently predicted abnormal microvascular function. CONCLUSIONS: Patients with chest pain and nonobstructive CAD have a high prevalence of coronary microvascular abnormalities. These abnormalities correlate poorly with conventional cardiovascular risk factors and are dissociated from the findings of noninvasive functional testing.
OBJECTIVES: This study assessed the prevalence of coronary microvascular abnormalities in patients presenting with chest pain and nonobstructive coronary artery disease (CAD). BACKGROUND:Coronary microvascular abnormalities mediate ischemia and can lead to an increased risk of cardiovascular events. METHODS: Using an intracoronary Doppler guidewire, endothelial-dependent microvascular function was examined by evaluating changes in coronary blood flow in response to acetylcholine, whereas endothelial-independent microvascular function was examined by evaluating changes in coronary flow velocity reserve in response to intracoronary adenosine. Patients were divided into 4 groups depending on whether they had a normal (+) or abnormal (-) coronary blood flow (CBF) in response to acetylcholine (Ach) and a normal (+) or abnormal (-) coronary flow velocity reserve (CFR) in response to adenosine (Adn): CBFAch+, CFRAdn+ (n = 520); CBFAch-, CFRAdn+ (n = 478); CBFAch+, CFRAdn- (n = 173); and CBFAch-, CFRAdn- (n = 268). RESULTS: Two-thirds of all patients had some sort of microvascular dysfunction. Women were more prevalent in each group (56% to 82%). Diabetes was uncommon in all groups (7% to 12%), whereas hypertension and hyperlipidemia were relatively more prevalent in each group, although rates for most conventional cardiovascular risk factors did not differ significantly between groups. There were no significant differences in the findings of noninvasive functional testing between groups. In a multivariable analysis, age was the only variable that independently predicted abnormal microvascular function. CONCLUSIONS:Patients with chest pain and nonobstructive CAD have a high prevalence of coronary microvascular abnormalities. These abnormalities correlate poorly with conventional cardiovascular risk factors and are dissociated from the findings of noninvasive functional testing.
Authors: Jaime L Shaw; Michael D Nelson; Janet Wei; Manish Motwani; Sofy Landes; Puja K Mehta; Louise E J Thomson; Daniel S Berman; Debiao Li; C Noel Bairey Merz; Behzad Sharif Journal: Int J Cardiol Date: 2018-06-22 Impact factor: 4.164
Authors: Hernán Mejía-Rentería; Nina van der Hoeven; Tim P van de Hoef; Julius Heemelaar; Nicola Ryan; Amir Lerman; Niels van Royen; Javier Escaned Journal: Int J Cardiovasc Imaging Date: 2017-05-13 Impact factor: 2.357
Authors: Arnav Kumar; Olivia Y Hung; Marina Piccinelli; Parham Eshtehardi; Michel T Corban; David Sternheim; Boyi Yang; Adrien Lefieux; David S Molony; Elizabeth W Thompson; Wenjie Zeng; Yasir Bouchi; Sonu Gupta; Hossein Hosseini; Mohamad Raad; Yi-An Ko; Chang Liu; Michael C McDaniel; Bill D Gogas; John S Douglas; Arshed A Quyyumi; Don P Giddens; Alessandro Veneziani; Habib Samady Journal: JACC Cardiovasc Interv Date: 2018-09-26 Impact factor: 11.195
Authors: Vijay Kunadian; Alaide Chieffo; Paolo G Camici; Colin Berry; Javier Escaned; Angela H E M Maas; Eva Prescott; Nicole Karam; Yolande Appelman; Chiara Fraccaro; Gill Louise Buchanan; Stephane Manzo-Silberman; Rasha Al-Lamee; Evelyn Regar; Alexandra Lansky; J Dawn Abbott; Lina Badimon; Dirk J Duncker; Roxana Mehran; Davide Capodanno; Andreas Baumbach Journal: Eur Heart J Date: 2020-10-01 Impact factor: 29.983
Authors: Seong-Mi Park; Janet Wei; Galen Cook-Wiens; Michael D Nelson; Louise Thomson; Daniel Berman; Eileen Handberg; John Petersen; David Anderson; Carl J Pepine; C Noel Bairey Merz Journal: Eur Heart J Cardiovasc Imaging Date: 2019-08-01 Impact factor: 6.875